Jun Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jun Zhao has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
Donglan Zeng
Department of Clinical Immunology Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
2 shared publicationsJingrong Chen
Division of Rheumatology, Department of Internal Medicine, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
2 shared publicationsJunlong Dang
Department of Pathology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China
2 shared publications- Song Guo Zheng
Department of Immunology, School of Cell and Gene Therapy, Shanghai Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 shared publications Wenbin Wu
Department of Spine Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
2 shared publicationsBing Sun
Department of Immunology, Institute of Biochemistry at Chinese Academy of Science, Shanghai 200031, China
1 shared publication
Latest Publications
- Open Access
- 10 May 2023
- Published by Elsevier in Journal of Advanced Research
- Vol. 58, 79-91
Infusion of GMSCs relieves autoimmune arthritis by suppressing the externalization of neutrophil extracellular traps via PGE2-PKA-ERK axis
- 10 May 2023
- Published by Elsevier in Journal of Advanced Research
- Vol. 58, 79-91
Open AccessInfusion of GMSCs relieves autoimmune arthritis by suppressing the externalization of neutrophil extracellular traps via PGE2-PKA-ERK axis
- Open Access
- 30 October 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (44) , eabb0606
Induced, but not natural, regulatory T cells retain phenotype and function following exposure to inflamed synovial fibroblasts
Aberrant number and/or dysfunction of CD4+Foxp3+ Regulatory T cells (Tregs) are associated with the pathogenesis of rheumatoid arthritis (RA). A previous study has demonstrated that thymus-derived, natural Tregs (nTregs) prefer to accumulate in inflamed joints and transdifferentiate to TH17 cells under the stimulation of inflamed synovial fibroblasts (SFs). In this study, we made a head-to-head comparison of both Treg subsets and demonstrated that induced Tregs (iTregs), but not nTregs, retained Foxp3 expression and regulatory function on T effector cells (Teffs) after being primed with inflamed SFs. In addition, iTregs inhibited proliferation, inflammatory cytokine production, migration, and invasion ability of collagen-induced arthritis (CIA)–SFs in vitro and in vivo. Moreover, we noted that iTregs directly targeted inflamed SFs to treat autoimmune arthritis, while nTregs failed to do this. Thus, manipulation of the iTreg subset may have a greater potential for prevention or treatment of patients with RA.
- 30 October 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (44) , eabb0606
Open AccessInduced, but not natural, regulatory T cells retain phenotype and function following exposure to inflamed synovial fibroblasts
Aberrant number and/or dysfunction of CD4+Foxp3+ Regulatory T cells (Tregs) are associated with the pathogenesis of rheumatoid arthritis (RA). A previous study has demonstrated that thymus-derived, natural Tregs (nTregs) prefer to accumulate in inflamed joints and transdifferentiate to TH17 cells under the stimulation of inflamed synovial fibroblasts (SFs). In this study, we made a head-to-head comparison of both Treg subsets and demonstrated that induced Tregs (iTregs), but not nTregs, retained Foxp3 expression and regulatory function on T effector cells (Teffs) after being primed with inflamed SFs. In addition, iTregs inhibited proliferation, inflammatory cytokine production, migration, and invasion ability of collagen-induced arthritis (CIA)–SFs in vitro and in vivo. Moreover, we noted that iTregs directly targeted inflamed SFs to treat autoimmune arthritis, while nTregs failed to do this. Thus, manipulation of the iTreg subset may have a greater potential for prevention or treatment of patients with RA.
- 1 May 2013
- Published by Elsevier in Materials Letters
- Vol. 98, 22-25
In vivo biocompatibility and biodegradation of a Mg-15%Ca3(PO4)2 composite as an implant material
- 1 May 2013
- Published by Elsevier in Materials Letters
- Vol. 98, 22-25
In vivo biocompatibility and biodegradation of a Mg-15%Ca3(PO4)2 composite as an implant material